N	Concordance
1	phylline with applications in automated immunoassay of the drug in biofluids usi
2	tic studies. Two commercially available immunoassays, based on the same monoclon
3	es. We have applied two microwell-based immunoassays which are capable of quanti
4	lasses. The new focused antigen capture immunoassay (FACIA) allows us to separat
5	 those obtained by the chemiluminescent immunoassay method or the chemiluminesce
6	reverse hybridization assay and the DNA immunoassay specifically identified HCV 
7	disturb a large array of latex-enhanced immunoassays used for routine diagnostic
8	>A new monoclonal antibody-based enzyme immunoassay (Innogenetics) for the detec
9	F1C phenotypes was tested by dot enzyme immunoassay with the corresponding monoc
10	d cells by quantitative sandwich enzyme immunoassay method (ELISA). LH alpha-SU 
11	d a particle concentration fluorescence immunoassay (PCFIA) were compared for th
12	 prepared to develop a hemagglutination immunoassay for beta-microseminoprotein 
13	, we employed competitive enzyme-linked immunoassays to measure concentrations o
14	ration by the fluorescence polarization immunoassay in the ultrafiltrate of seru